Neurological Surgery·Burlington, VT

University of Vermont Medical Center

Signal lift20%73%+53 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
237–264
p10 – p90
Sample N
296
applicants this cycle
This cycle
-
no tracked aways yet
Match rate
0.3%
1 of 296 applicants
01Cohort funnelthis cycle
N = 296
Applied
296
100.0%
Invited
30
10.1%
Class size
1
0.3%
J-1 visaCategorical
Your fitUniversity of Vermont Medical Center Program

Create a free profile to see your personalized fit

Get started

Who to contact

Training sites2 hospitals
  • 1
    University of Vermont Medical Center
    Burlington, VT
    Primary
  • 2
    University of Utah Health
    Salt Lake City, UT
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK237 – 264
180205230255280

Level 2 CE data not available

Interview rates
US MD
12%
US DO
20%
US IMG
0%
Non-US IMG
2%
Applicant origin
In-state
0%
Out-of-state
10%
Interview prepNeurological Surgery
specialtyWhat draws you to neurosurgery despite the demanding lifestyle?★ common
clinicalDescribe a case that solidified your interest in neurosurgery.★ common
behavioralHow do you handle the emotional burden of high-mortality cases?
specialtyWhat subspecialty within neurosurgery interests you?★ common
personalDiscuss your research and how it applies to neurosurgery.★ common
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesNeurological Surgery · 25-26
Save this program

Add University of Vermont Medical Center to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Neurological Surgery.

See how your profile compares across all programs.

Open calculator →

Program data, 2025 release. Not medical advice. © 2026 Rezumab LLC.